NCT05044819 2026-03-17
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Jazz Pharmaceuticals
Phase 4 Active not recruiting
Jazz Pharmaceuticals
Jazz Pharmaceuticals
ZYUS Life Sciences Inc.
Dana-Farber Cancer Institute